Why Do I Feel Bad After a Testosterone Cycle? (TRT Q&As)
Timeline
A 37-year-old man reports fatigue and loss of libido after a higher-dose testosterone cycle, along with frequent blood donation, low ferritin, and subsequent iron supplementation. Dr. O’Connor reviews his androgen history, iron and blood counts, medications, sleep apnea, cardiovascular risk, mental health, and aromatase inhibitor use, emphasizing that multiple factors may be contributing rather than assuming estrogen alone is responsible.
The member says increasing testosterone to 250 mg weekly and adding 100 mg of Deca dramatically improved anxiety, sleep, libido, and sexual function. Dr. O’Connor acknowledges the improvement but cautions that the effect may not remain sustainable and stresses monitoring blood pressure, cholesterol, hematology, heart health, and the other ABCDs™ as androgen exposure increases.
A 49-year-old man who has never used testosterone or anabolic steroids describes repeatedly low testosterone, low free testosterone, fatigue, and reduced sexual drive. Dr. O’Connor says his symptoms and repeated laboratory findings make him a reasonable candidate for a carefully monitored testosterone trial after evaluating his overall health and cardiovascular risk.
The member wants a conservative starting dose rather than a bodybuilding-level regimen. Dr. O’Connor discusses starting around 100 mg every five days while emphasizing individualized treatment, follow-up laboratory testing, symptom response, and avoiding unnecessary aromatase inhibitor use.
The member is considering nandrolone because severe arthritis and bone-on-bone joint problems make training difficult. Dr. O’Connor discusses potential joint-pain benefits but also emphasizes nandrolone’s cardiovascular and sexual risks, ultimately favoring a more cautious approach and discussing other options rather than casually adding Deca.
Dr. O’Connor explains that testosterone can increase sebum production and cause acne-like breakouts. He recommends using the lowest effective testosterone dose, considering more frequent dosing, and treating the acne directly rather than automatically suppressing estrogen, including discussing topical clindamycin for limited breakouts.
Video Summary
The discussion centers on how testosterone therapy should be adjusted cautiously once a stable response is achieved. It emphasizes resisting frequent protocol changes driven by short-term symptom fluctuation. Consistency is highlighted as a key factor in reliable assessment.
A central segment reviews laboratory monitoring and why trends across time provide more insight than isolated values. The episode explains how overreaction to single lab results can disrupt otherwise effective therapy. Measured interpretation is reinforced.
The closing portion integrates testosterone therapy into long-term clinical planning. Ongoing monitoring, individualized adjustment, and risk awareness are emphasized. Hormone therapy is framed as a longitudinal process rather than a series of quick fixes.
Drug Callouts
Condition Callouts
Key Takeaways
- Stability should be prioritized once testosterone therapy is effective.
- Frequent protocol changes can undermine symptom consistency.
- Lab trends are more informative than isolated abnormalities.
- Overreaction to single values may disrupt effective therapy.
- Long-term monitoring supports safer hormone management.